Choose Rich Live
Tech

Ex-OpenAI executive Kevin Weil launches Warp Sciences with $215 million

Former OpenAI product chief Kevin Weil has launched Warp Sciences, an AI-powered drug development startup that emerged from stealth with $215 million in funding at an $865 million valuation.

Kevin Weil, the former OpenAI chief product officer who led the company's AI-for-science initiatives, has emerged from stealth with a new startup named Warp Sciences. Bloomberg reported that the venture raised $215 million in funding, establishing a post-money valuation of $865 million for the company.[1][3][4]

Warp Sciences aims to accelerate pharmaceutical research and drug development using artificial intelligence. According to tech account MTS, the startup is developing robotics- and AI-powered laboratories to expedite the discovery process, reflecting an expanding push across the tech sector to apply artificial intelligence tools to scientific discovery.[1][2][4][5]

Key facts

  • Former OpenAI Chief Product Officer Kevin Weil launched the startup Warp Sciences.
  • Weil previously led AI-for-science efforts at OpenAI.
  • Warp Sciences emerged from stealth with $215 million in funding.
  • Bloomberg reported that the financing gives Warp Sciences an $865 million post-money valuation.
  • The company focuses on using AI to speed up drug discovery and development.
  • Warp Sciences is building AI- and robotics-powered laboratories to accelerate research.

Sources · 5 sources

  1. TE

    Techmeme@TechmemePost on X ·

    Warp Sciences, founded by ex-OpenAI product chief Kevin Weil to speed up AI drug development, emerges from stealth with $215M at an $865M post-money valuation (@rebeccatorrenc5 / Bloomberg) (Visit Techmeme dot com for the link and full context!)

    Open source
  2. CB

    Crypto BriefingArticle ·

    Ex-OpenAI executive raises $215 million for AI drug development startup The launch highlights the growing trend of leveraging AI in scientific research, emphasizing high expectations for innovation and impact. The post Ex-OpenAI executive raises $215 million for AI drug development startup appeared first on Crypto Briefing .

    Open source
  3. BL

    Bloomberg@businessPost on X ·

    Ex-OpenAI science head Kevin Weil launches startup with $215 million https://t.co/mTAKSv4Mze

    Open source
  4. TE

    TechmemeArticle ·

    Warp Sciences, founded by former OpenAI CPO Kevin Weil to speed up drug development using AI, emerges from stealth with $215M at an $865M post-money valuation (Rebecca Torrence/Bloomberg) Rebecca Torrence / Bloomberg : Warp Sciences, founded by former OpenAI CPO Kevin Weil to speed up drug development using AI, emerges from stealth with $215M at an $865M post-money valuation — Kevin Weil, the former OpenAI executive who led the ChatGPT maker's AI-for-science efforts, is launching a new startup aimed …

    Open source
  5. MT

    MTS@MTSlivePost on X ·

    SITUATION DETECTED: Former OpenAI CPO Kevin Weil has launched his startup Warp Sciences from stealth with $215 million in funding. The company is building AI and robotics-powered labs to accelerate drug discovery.

    Open source